|
|
|
|
| LEADER |
00000cam a2200000 c 4500 |
| 001 |
1892189291 |
| 003 |
DE-627 |
| 005 |
20240627104441.0 |
| 007 |
tu |
| 008 |
240625s2024 gw ||||| m 00| ||eng c |
| 035 |
|
|
|a (DE-627)1892189291
|
| 035 |
|
|
|a (DE-599)KXP1892189291
|
| 035 |
|
|
|a (OCoLC)1442067238
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-DE-BW
|
| 084 |
|
|
|a 32
|2 sdnb
|
| 100 |
1 |
|
|a Baltissen, Danny
|d 1993-
|e VerfasserIn
|0 (DE-588)1230170839
|0 (DE-627)175263263X
|4 aut
|
| 245 |
1 |
0 |
|a Evaluating APPsα as a potential therapeutic agent in Tauopathies
|b a study in Tau transgenic mice
|c presented by Danny Baltissen, M.Sc. ; referees: Prof. Dr. Ulrike Müller, Prof. Dr. Joachim Kirsch
|
| 246 |
3 |
3 |
|a Evaluating APPsa as a potential therapeutic agent in Tauopathies
|
| 264 |
|
1 |
|a Heidelberg
|c 2024
|
| 300 |
|
|
|a XXII, 155 Seiten
|b Illustrationen, Diagramme
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 502 |
|
|
|b Dissertation
|c Ruprecht-Karls-University Heidelberg
|d 2024
|
| 546 |
|
|
|a Text Englisch, Zusammenfassung in englischer und deutscher Sprache
|
| 655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
| 700 |
1 |
|
|a Erb, Ulrike
|d 1983-
|e AkademischeR BetreuerIn
|0 (DE-588)1058511963
|0 (DE-627)797037349
|0 (DE-576)414695062
|4 dgs
|
| 710 |
2 |
|
|a Universität Heidelberg
|e Grad-verleihende Institution
|0 (DE-588)2024349-2
|0 (DE-627)102161488
|0 (DE-576)191769517
|4 dgg
|
| 751 |
|
|
|a Heidelberg
|0 (DE-588)4023996-2
|0 (DE-627)106300814
|0 (DE-576)208952578
|4 uvp
|
| 951 |
|
|
|a BO
|
| 992 |
|
|
|a 20240627
|
| 993 |
|
|
|a Thesis
|
| 994 |
|
|
|a 2024
|
| 998 |
|
|
|g 1230170839
|a Baltissen, Danny
|m 1230170839:Baltissen, Danny
|d 140000
|d 140001
|e 140000PB1230170839
|e 140001PB1230170839
|k 0/140000/
|k 1/140000/140001/
|p 1
|x j
|y j
|
| 999 |
|
|
|a KXP-PPN1892189291
|e 4542500985
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"name":{"displayForm":["presented by Danny Baltissen, M.Sc. ; referees: Prof. Dr. Ulrike Müller, Prof. Dr. Joachim Kirsch"]},"id":{"eki":["1892189291"]},"origin":[{"publisherPlace":"Heidelberg","dateIssuedKey":"2024","dateIssuedDisp":"2024"}],"physDesc":[{"noteIll":"Illustrationen, Diagramme","extent":"XXII, 155 Seiten"}],"person":[{"given":"Danny","family":"Baltissen","role":"aut","roleDisplay":"VerfasserIn","display":"Baltissen, Danny"},{"roleDisplay":"AkademischeR BetreuerIn","display":"Erb, Ulrike","role":"dgs","family":"Erb","given":"Ulrike"}],"noteThesis":["Dissertation. - Ruprecht-Karls-University Heidelberg. - 2024"],"title":[{"title":"Evaluating APPsα as a potential therapeutic agent in Tauopathies","subtitle":"a study in Tau transgenic mice","title_sort":"Evaluating APPsα as a potential therapeutic agent in Tauopathies"}],"recId":"1892189291","language":["eng"],"corporate":[{"role":"dgg","roleDisplay":"Grad-verleihende Institution","display":"Universität Heidelberg"}],"type":{"bibl":"thesis"},"titleAlt":[{"title":"Evaluating APPsa as a potential therapeutic agent in Tauopathies"}]}
|
| SRT |
|
|
|a BALTISSENDEVALUATING2024
|
